AZEDRA (IOBENGUANE I-131) — FDA Approval NDA209607 (PROGENICS PHARMS INC)
AZEDRA (IOBENGUANE I-131) — FDA Approval NDA209607 (PROGENICS PHARMS INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: AZEDRA; Active ingredients: IOBENGUANE I-131; Application number: NDA209607.
| Brand name | AZEDRA |
|---|---|
| Active ingredients | IOBENGUANE I-131 |
| Application number | NDA209607 |
| Sponsor | PROGENICS PHARMS INC |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20180730 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →